beyfortus
astrazeneca ab - nirsevimab - immune sera and immunoglobulins, - beyfortus is indicated for the prevention of respiratory syncytial virus (rsv) lower respiratory tract disease in neonates and infants during their first rsv season.beyfortus should be used in accordance with official recommendations.
sevelamer hydrochloride sanofi sevelamer hydrochloride 800 mg tablet bottle
sanofi-aventis australia pty ltd - sevelamer hydrochloride -
sevelamer hydrochloride sanofi sevelamer hydrochloride 400 mg tablet bottle
sanofi-aventis australia pty ltd - sevelamer hydrochloride -
sevelamer carbonate sanofi sevelamer carbonate 2.4 g powder for oral suspension sachet
sanofi-aventis australia pty ltd - sevelamer carbonate -
sevelamer carbonate sanofi sevelamer carbonate 800 mg tablet bottle
sanofi-aventis australia pty ltd - sevelamer carbonate -
sevelamer carbonate sanofi sevelamer carbonate 1.6 g powder for oral suspension sachet
sanofi-aventis australia pty ltd - sevelamer carbonate -
lixisenatide sanofi treatment initiation pack 10mcg (0.05 mg/ml) and 20 mcg (0.1) mg/ml solution for injection injector pen
sanofi-aventis australia pty ltd - lixisenatide -
teriflunomide sanofi teriflunomide 14 mg film-coated tablets blister pack
sanofi-aventis australia pty ltd - teriflunomide -
sanofi caplets tablet blister pack
sanofi-aventis australia pty ltd - codeine phosphate hemihydrate,doxylamine succinate,paracetamol -
risedronate sanofi ec
sanofi-aventis australia pty ltd - risedronate sodium; calcium carbonate; colecalciferol; cholecalciferol -